Skip to main content

Table 1 Available studies (NCT = ClinicalTrials.gov registry number)

From: Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data

CTR

   Condition

   NCT

   Published study

1VIT04004 [44]

   Chronic kidney disease

 

   Qunibi et al. Nephrol Dial Transplant 2010 doi: 10.1093/ndt/gfq613 [45]

1VIT04005 [47]

   Chronic kidney disease

 

   No publication identified

VIT-IV-CL-015 [46]

   Haemodialysis

 

   No publication identified

53214 [48]

   Haemodialysis

 

   Covic & Mircescu. Nephrol Dial Transplant 2010 25: 2722-2730 [49]

VIT-IV-CL-009 [50]

   Post partum anaemia

 

   Breymann et al. Int J Gynecol Obstet 2008 101: 67-73 [51]

1VIT06011 [52]

   Post partum anaemia

 

   Seid et al. Am J Obstet Gynecol 2008 199:435.e1-7 [53]

1VIT04002/4003 [54]

   Uterine bleeding

   NCT00395993

   Van Wyck et al. Transfusion 2009 49: 2719-2728 [41]

No CTR available

   Post partum anaemia

   NCT00396292

   Van Wyck et al. Obst & Gynecol 2007 110:267-278 [55]

VIT-IV-CL-03 [56]

   GI causes of anaemia

 

   No publication identified

VIT-IV-CL-008 [57]

   Inflammatory bowel disease

 

   Kulnigg et al. Am J Gastroeneterol 2008 24:1507-1523 [58]

1VIT05006 [59]

   Iron deficiency anaemia

 

   Bailie et al. Hemodialysis International 2010 14: 47-54 [35]

CARS 1 [60]

   Iron deficiency anaemia

 

   No publication identified

No CTR available

   Congestive heart failure

   NCT00520780

   Anker et al. NEJM 2009 361 [42]

No CTR available

   CKD design

   NCT00981045

   Szczech et al. Nephrol Dial Transplant 2010 25: 2368-2375 [61]